Charity Impact Media

Home › Medical research

Conquer Cancer Foundation of the American Society of Clinical Oncology

Also known as Conquer Cancer & Conquer Cancer Fdtn

Alexandria, VA · EIN 31-1667995 · 501(c)(3) · Publicly supported organization (170(b)(1)(A)(vi))
Latest filing: Form 990 for calendar year 2024 (tax year 2024) · View the filing · Correct or respond

Conquer Cancer Foundation of the American Society of Clinical Oncology reported $41.4 million in revenue and $34.8 million in expenses for calendar year 2024. Of every $100 it spent, $66.81 went to program services, $4.72 to management and general costs and $28.47 to fundraising. Its largest source of revenue was contributions and grants: 90.1% of the total. The highest compensation it reported for one person was $1,139,916 (EXECUTIVE VICE CHAIR). Revenue rose 36% between 2019 and 2024. Source: Form 990, 2024.

Where $100 of spending went

Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $35M

For context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).

Where $100 of revenue came from

Calendar year 2024 · Form 990, Part VIII · total revenue $41M

Other revenue was negative: −$266K. The bar shows the positive sources only.

The 990 scorecard · same measures for every charity, no grades

2024 filing. Median across 169 covered charities in this category, from their latest filings.
Measure2024Median
Program services
Part IX 25(B) ÷ 25(A)
66.8%83.9%
Management & general
Part IX 25(C) ÷ 25(A)
4.7%12.4%
Fundraising
Part IX 25(D) ÷ 25(A)
28.5%0.1%
Fundraising cost per $1 of contributions
Part IX 25(D) ÷ Part VIII 1h
$0.27$0.01
Contributions & grants share of revenue
Part VIII 1h ÷ 12
90.1%72.7%
Government grants share of revenue
Part VIII 1e ÷ 12
0.0%0.0%
Program service revenue share
Part VIII 2g ÷ 12
0.9%5.8%
Highest reported compensation
Part VII-A, columns D–F
$1,139,916$628,890
Highest compensation as share of expenses
Part VII-A ÷ Part IX 25(A)
3.28%1.94%
People paid over $100,000
Part VII, line 2
018
Net assets, in months of expenses
Part X 33(B) ÷ monthly expenses
37.313.3
Independent voting board members
Part VI 1a–1b
20 of 2193.8%

A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.

What the money paid for, in its own words

2024 · Form 990, Part III · the three largest programs by expense
$16M expenses · 68.2% of program spending · grants $12M · revenue $364K

No description in Part III; see the filing.

$6.1M expenses · 26.3% of program spending · grants $5.9M

No description in Part III; see the filing.

$1.3M expenses · 5.4% of program spending · grants $1.0M

No description in Part III; see the filing.

Highest reported compensation

2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here
RoleFrom this orgFrom related orgsOtherTotal
EXECUTIVE VICE CHAIR
Director/trustee, officer, 6.50 hrs/week
$0$1,114,041$25,875$1,139,916
CEO & EXECUTIVE VP
Officer, 36.50 hrs/week
$0$536,218$47,217$583,435
CFO (PARTIAL YEAR)
Officer, 1.00 hrs/week
$0$259,970$24,887$284,857

0 people received more than $100,000 in reportable compensation from Conquer Cancer Foundation of the American Society of Clinical Oncology (Part VII, line 2).

6 years of filings

Form 990, Parts I, VII, IX and X · each row is that year's own filing, linked
RevenueExpenses
$0$20M$40M$60M$80M201920202021202220232024$41M$35M
FilingRevenueExpensesProgramsNet assetsTop pay
2024 ⓘ$41M$35M66.8%$108M$1,139,916
2023 ⓘ$39M$34M72.3%$97M$1,085,551
2022 ⓘ$33M$33M74.0%$84M$952,895
2021 ⓘ$25M$28M75.7%$100M$910,475
2020 ⓘ$33M$25M74.3%$99M$972,019
2019 ⓘ$30M$25M76.4%$82M$922,427

Governance answers, as filed

2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means
  • Voting board members, and how many are independent Part VI, lines 1a–1b21 · 20 independent
  • Audited financial statements Part XII 2bYes
  • Conflict-of-interest policy Part VI 12aYes
  • Whistleblower policy Part VI 13Yes
  • Document retention policy Part VI 14Yes
  • Independent process for top executive pay Part VI 15aNo
  • Board given the 990 before filing Part VI 11aYes
  • Family or business ties among insiders Part VI 2No
  • Aware of a significant diversion of assets Part VI 5No
  • Excess benefit transaction with an insider Part IV 25aNo
  • Loans to or from insiders outstanding Part IV 26No
  • Lobbying, or a 501(h) election in effect Part IV 4No
  • Over $15,000 of professional fundraising services Part IV 18Yes
  • Over $10,000 of activity outside the U.S. Part IV 14bYes
  • Employees Part I, line 50
  • Volunteers Part I, line 6300

Largest outside contractors

2024 · Form 990, Part VII, Section B · businesses only
RKD GROUP LLC
Pro fundraising services
$176,389
THE HARRINGTON AGENCY
Pro fundraising services
$124,750

Individuals listed as contractors are left out. 2 contractors were paid more than $100,000 in all.

Private foundation grants it received

13 private foundations reported grants to Conquer Cancer Foundation of the American Society of Clinical Oncology totaling $1.2M on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.

Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.

Correct a figure or respond

Every number above is copied from Conquer Cancer Foundation of the American Society of Clinical Oncology's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Conquer Cancer Foundation of the American Society of Clinical Oncology, you can publish a response that is linked from this page.

Similar-sized charities in this cause

All medical research charities · Largest charities in Virginia

Questions people ask

How much of Conquer Cancer Foundation of the American Society of Clinical Oncology's spending goes to programs?

In calendar year 2024, Conquer Cancer Foundation of the American Society of Clinical Oncology reported that 66.8% of its $34.8 million in expenses went to program services, 4.7% to management and general and 28.5% to fundraising (Form 990, Part IX).

How much does Conquer Cancer Foundation of the American Society of Clinical Oncology pay its top executive?

The largest total compensation Conquer Cancer Foundation of the American Society of Clinical Oncology reported for one person in calendar year 2024 was $1,139,916, for the role of EXECUTIVE VICE CHAIR (Form 990, Part VII, including compensation from related organizations and other compensation).

Where does Conquer Cancer Foundation of the American Society of Clinical Oncology get its money?

Of $41.4 million in revenue in calendar year 2024, 90.1% came from contributions and grants and 0.9% from program service revenue (Form 990, Part VIII).

Is Conquer Cancer Foundation of the American Society of Clinical Oncology a registered charity?

The IRS lists EIN 31-1667995 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.

Sources

  • 2024: Form 990 for calendar year 2024, object 202523159349304327 · read the filing · XML
  • 2023: Form 990 for calendar year 2023, object 202403209349300045 · read the filing
  • 2022: Form 990 for calendar year 2022, object 202332719349301118 · read the filing
  • 2021: Form 990 for calendar year 2021, object 202242839349300549 · read the filing
  • 2020: Form 990 for calendar year 2020, object 202132929349301603 · read the filing
  • 2019: Form 990 for calendar year 2019, object 202042959349300814 · read the filing

All filings for EIN 31-1667995: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.